Novelna is a biotechnology and AI company specializing in cancer diagnostics. Their mission is to make early disease detection universally accessible. They emphasize enhancing accessibility, accuracy, and affordability in disease diagnostics. Novelna employs the Proximity Extension Assay (PEA) technology, integrating protein measurement with AI for advanced biomarker discovery in cancers and other diseases. The company aims to balance financial success with positive societal impact through their approach to early cancer detection.